Aug 3, 2016 | 2016, Press Releases, Scientific
Philogen S.p.A. announced that they have entered into a collaboration, option and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop a new class of immunomodulatory therapeutics....Jul 25, 2016 | 2016, Press Releases, Scientific
Philogen SpA announced the successful GMP production of PHC-102 for the imaging of renal cell carcinoma and other carbonic anhydrase expressing tumors PHILOGEN SPA ANNOUNCED THE SUCCESSFUL GMP PRODUCTION OF PHC-102Feb 15, 2016 | 2016, Press Releases, Scientific
PHILOGEN ANNOUNCES EXPANDED RESEARCH AND DEVELOPMENT AGREEMENT WITH ABBVIEJan 21, 2016 | 2016, Press Releases, Scientific
Philogen S.p.A announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach. Siena, 21st January 2016. PRESS RELEASE MELANOMA PHASE...Jan 21, 2016 | 2016, Press Releases, Scientific
Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014 for the potential development and commercialization of multiple antibody drug conjugates (ADCs). Siena, Italy, 21st January 2016....
Recent Comments